Literature DB >> 11974526

[Helicobacter pylori genotypes in non atrophic gastritis are different of the found in peptic ulcer, premalignant lesions and gastric cancer in Colombia].

Diana M Cittelly1, Mónica G Huertas, Julián D Martínez, Ricardo Oliveros, Héctor Posso, María Mercedes Bravo, Oscar Orozco.   

Abstract

BACKGROUND: Helicobacter pylori is recognized as an etiologic agent of several gastric diseases. Bacterial genotypes have been related to clinical outcome in several populations. AIM: To compare cagA, vacA and iceA genotypes of Colombian isolates from patients with several gastrointestinal diseases, including gastric cancer.
MATERIAL AND METHODS: We used polymerase chain reactions to amplify vacA, cagA and iceA genes of 137 H pylori isolates coming from 26 patients with gastric cancer (GC), 34 with peptic ulcer (PU), 19 with intestinal metaplasia (IM), 23 with atrophic gastritis (AG) and 35 with non atrophic gastritis (NAG).
RESULTS: vacA s1-m1, cagA+, iceA+ were the most frequently found genotypes. vacA s1 and m1 subtypes were found in 92 (67%) and 82 (60%) cases respectively. Sixty three percent were cagA+ and 85% were iceA+. There was a lower prevalence of s1 allele in cases of NAG (43%), compared with GC, PU and IM (81%, 77% and 81% prevalence, respectively, p < 0.01). Isolates from NAG also showed a low frequency of vacA m1 subtype (40%) compared with GC or IM (81% and 84% respectively, p < 0.01). The prevalence of cagA+ strains was significantly higher in GC patients (80%) than in NAG patients (51.4%, p < 0.01). No differences in the frequency of vacA s1a, s1b and iceA subtypes, were observed.
CONCLUSIONS: A lower frequency of cytotoxic H pylori genotypes such as cagA and vacA s1m1 and a higher frequency of non cytotoxic genotypes, was observed in patients with NAG, when compared to patients with GC or PU. These results suggest that even in Colombia, vacA and cagA could be used as markers of increased virulence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11974526

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  5 in total

1.  cagA and vacA genotype of Helicobacter pylori associated with gastric diseases in Xi'an area.

Authors:  Wen Qiao; Jia-Lu Hu; Bing Xiao; Kai-Chun Wu; Dao-Rong Peng; John C Atherton; Hui Xue
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.

Authors:  M Constanza Camargo; M Blanca Piazuelo; Robertino M Mera; Elizabeth T H Fontham; Alberto G Delgado; M Clara Yepez; Cristina Ceron; Luis E Bravo; Juan C Bravo; Pelayo Correa
Journal:  Acta Gastroenterol Latinoam       Date:  2007-12

3.  Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer.

Authors:  Carlos A Castaneda; Miluska Castillo; Iván Chavez; Fernando Barreda; Nancy Suarez; Jais Nieves; Luis A Bernabe; Daniel Valdivia; Eloy Ruiz; Emmanuel Dias-Neto; Maria P Landa-Baella; Yaqueline Bazan; Carlos A Rengifo; Paola Montenegro
Journal:  J Glob Oncol       Date:  2019-09

4.  Virulence Genes of Helicobacter pylori Increase the Risk of Premalignant Gastric Lesions in a Colombian Population.

Authors:  Yeison Carlosama-Rosero; Claudia Acosta-Astaiza; Carlos H Sierra-Torres; H Bolaños-Bravo; Andrés Quiroga-Quiroga; Juan Bonilla-Chaves
Journal:  Can J Gastroenterol Hepatol       Date:  2022-09-28

5.  Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014).

Authors:  Alba A Trespalacios-Rangél; William Otero; Azucena Arévalo-Galvis; Raúl A Poutou-Piñales; Emiko Rimbara; David Y Graham
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.